DXCM (DXCM) Stock Price & Analysis
DXCM (DXCM) fell 3.07% to USD 85.2 as of September 8, 2026 at 17:07 UTC, according to Nexqual real-time market data.
DXCM last closed at USD 85.2; the session ranged USD 84.24–86.75 on volume of 2,091,845 shares. Market capitalization is —, with a 52-week range of USD 54.11–92.59 (NMS). Source: Nexqual, September 8, 2026 at 17:07 UTC.
Key Statistics (as of September 8, 2026 at 17:07 UTC)
| Price | USD 85.2 |
|---|---|
| Change | ▼ 3.07% (down) |
| Previous Close | USD 85.2 |
| Open | USD 85.2 |
| Day Range | USD 84.24 – 86.75 |
| 52-Week Range | USD 54.11 – 92.59 |
| Volume | 2,091,845 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (DXCM)
Nexqual's technical model rates DXCM "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of September 8, 2026 at 17:07 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 49.53 (neutral) |
| vs SMA50 | Above (USD 81.52) |
| MACD | 1.71 (positive) |
From DXCM's Latest SEC 10-K Filing (filed 2026-02-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PODD | Insulet Corporation | USD 141.42 | ▼ 6.08% |
| IDXX | IDEXX Laboratories, Inc. | USD 526.72 | ▼ 0.49% |
| ALGN | Align Technology, Inc. | USD 155.04 | ▼ 3.02% |
| VEEV | Veeva Systems Inc. | USD 264.65 | ▼ 6.94% |
| VRTX | Vertex Pharmaceuticals Incorpor | USD 527.86 | ▼ 5.39% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 17:07 UTC. This page is informational and not investment advice.